|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
115,717,000 |
Market
Cap: |
N/A |
Last
Volume: |
1,565,825 |
Avg
Vol: |
726,369 |
52
Week Range: |
$2.39 - $2.39 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Monko Alexander Michael |
Sr. VP, Genetic Analysis |
|
2014-02-10 |
4 |
D |
$2.34 |
$6,676 |
D/D |
(2,853) |
37,721 |
|
- |
|
Monko Alexander Michael |
Sr. VP, Genetic Analysis |
|
2014-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
40,574 |
|
- |
|
Hixson Harry F Jr |
CEO |
|
2014-02-10 |
4 |
D |
$2.34 |
$20,934 |
D/D |
(8,946) |
172,856 |
|
- |
|
Hixson Harry F Jr |
CEO |
|
2014-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
20,438 |
181,802 |
|
- |
|
Lindsay Ronald M |
Director |
|
2014-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,363 |
201,104 |
|
- |
|
Maier Paul V |
Chief Financial Officer |
|
2014-02-10 |
4 |
D |
$2.34 |
$7,343 |
D/D |
(3,138) |
63,789 |
|
- |
|
Maier Paul V |
Chief Financial Officer |
|
2014-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,150 |
66,927 |
|
- |
|
Beaver Carolyn |
VP and Chief Accounting Ofcr |
|
2014-02-10 |
4 |
D |
$2.34 |
$1,762 |
D/D |
(753) |
24,609 |
|
- |
|
Beaver Carolyn |
VP and Chief Accounting Ofcr |
|
2014-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,714 |
25,362 |
|
- |
|
Lai Goldman Myla |
Director |
|
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
19,742 |
35,200 |
|
- |
|
Buechler Kenneth F |
Director |
|
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
24,892 |
54,892 |
|
- |
|
Pendarvis David |
Director |
|
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
25,751 |
61,724 |
|
- |
|
Lerner Richard A |
Director |
|
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
21,459 |
27,383 |
|
- |
|
Welch William J |
President & COO |
|
2013-12-10 |
4 |
D |
$2.34 |
$9,620 |
D/D |
(4,111) |
21,577 |
|
- |
|
Welch William J |
President & COO |
|
2013-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
10,938 |
25,688 |
|
- |
|
Van Den Boom Dirk |
EVP & Chief Tech. Officer |
|
2013-12-10 |
4 |
D |
$2.34 |
$8,246 |
D/D |
(3,524) |
44,561 |
|
- |
|
Van Den Boom Dirk |
EVP & Chief Tech. Officer |
|
2013-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
9,375 |
48,085 |
|
- |
|
Hixson Harry F Jr |
CEO |
|
2013-06-19 |
4 |
D |
$4.22 |
$118,941 |
D/D |
(28,185) |
152,154 |
|
- |
|
Hixson Harry F Jr |
CEO |
|
2013-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
180,339 |
|
- |
|
Bombard Allan |
Chief Medical Officer |
|
2013-06-19 |
4 |
D |
$4.22 |
$18,505 |
D/D |
(4,385) |
48,534 |
|
- |
|
Bombard Allan |
Chief Medical Officer |
|
2013-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11,666 |
52,919 |
|
- |
|
Judge Alisa |
VP, Human Resources |
|
2013-06-19 |
4 |
D |
$4.22 |
$11,103 |
D/D |
(2,631) |
7,765 |
|
- |
|
Judge Alisa |
VP, Human Resources |
|
2013-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
10,396 |
|
- |
|
Cantor Charles R |
Chief Scientific Officer |
|
2013-06-19 |
4 |
D |
$4.22 |
$11,103 |
D/D |
(2,631) |
17,644 |
|
- |
|
Cantor Charles R |
Chief Scientific Officer |
|
2013-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
20,275 |
|
- |
|
376 Records found
|
|
Page 5 of 16 |
|
|